Veterinary pharmacovigilance: how to report an adverse reaction

The common picture of an adverse reaction is the obvious toxic effect, but the definition used in pharmacovigilance is broader and includes situations that often go unreported because they seem irrelevant. An adverse reaction is any harmful and unintended response to a medicine, but also a lack of expected efficacy, an effect on the environment, a problem appearing in a human who came into contact with the product, and residues beyond expectations in animals intended for food.

• A harmful reaction after use in line with the leaflet, even mild or transient.
• A reaction after off-label use, for example a different dose or an unlisted species, which is still reported while stating that the use was off-label.
• Lack of efficacy: the drug does not produce the expected effect despite correct use, a possible sign of resistance or a product problem.
• A suspected reaction to a parasiticide sensed in the environment or on a person who handled the treated animal.
• A reaction in a human exposed to the medicine during administration, from skin contact to accidental self-injection.
• A suspected quality problem: abnormal appearance, a faulty container, behaviour different from usual.

The most common resistance to reporting comes from the idea that an event already described in the leaflet, or one that is not serious, adds nothing. That is not so. The real frequency of a reaction is reconstructed only by adding up many cases, and a rare effect can emerge only when enough people report it. A single episode of vomiting after a tablet does not change a drug's story; hundreds of reports of the same picture in the same period may reveal a problematic batch or a subpopulation at risk.

There is also a value that touches the individual animal directly. A reaction recorded precisely in its history keeps the same active substance from being reused carelessly in future, and lets you recognise a pattern when the picture repeats with drugs of the same class. Reporting to the system and recording in the animal's chart are two distinct but complementary acts: the first protects the population, the second protects the patient in front of you.

A medicine's safety is an estimate that keeps updating: each report shifts that estimate a little, and the sum of observations is worth more than the single registration study.

A useful report is a well described one. The data that make a case assessable are almost always the same, and collecting them while the event is fresh is worth more than reconstructing them from memory days later. The table sums up what to record, without replacing clinical judgement on what is relevant in the single case.

Reporting routes depend on the country and the type of product, but the shape of the path is similar everywhere: you can report to the competent authority for veterinary medicines or directly to the marketing authorisation holder, which in turn must pass the case on to the system. For up-to-date details on forms and channels it is best to refer to the national competent authority and to the package leaflet, where the holder gives its pharmacovigilance contacts.

1. 1

   Gather the data while the event is recent

   Use the scheme from the table above. Even an incomplete report beats none, but the more fields you fill in the more assessable the case becomes.

2. 2

   Find the right channel

   Check the leaflet for the holder's contacts and the competent authority's site for the official form. Parasiticides, vaccines and prescription medicines may have dedicated routes.

3. 3

   Describe facts, not interpretations

   Say what happened and in what order. Avoid filtering out signs that seem unrelated: selection is for those who assess, not those who report.

4. 4

   State whether use was on-label

   Declare openly if the drug was used off indication, dose or species. This does not disqualify the report, it makes it interpretable.

5. 5

   Also record it in the animal's history

   Reporting to the system does not replace the note in the individual chart, which protects that single animal from future re-exposure.

6. 6

   Keep the report number

   If the system returns an identifier, keep it with the case: it lets you add information should the clinical course bring new data.

The owner is often the first to notice something: a change of behaviour the same evening as the dose, itching after a parasiticide, food refusal that lasts longer than expected. The vet adds the clinical context, rules out other causes and turns the observation into an assessable picture. Both can report, and the two perspectives do not exclude each other: an owner report and a vet report on the same case are not an annoying duplicate but two viewpoints the system knows how to link.

• The owner describes timing, behaviour at home and the sequence of events as they saw them.
• The vet adds clinical examination, tests, differential diagnosis and management.
• Whoever applies a parasiticide also reports effects felt on themselves or in the home environment.
• On a farm or in a shelter a reaction repeating across several animals in the same group is reported as a group event, not only case by case.

The collaboration also has an educational effect. An owner who is told why reporting is worthwhile comes back to describe the next episode instead of filing it away as bad luck. And a practice that makes reporting part of its flow, rather than an exceptional chore, ends up generating better data on the real use of the drugs it prescribes.